This update includes: Alliance Snapshot of DEA Comments Federal Telehealth Support Program Faces Collapse Without Budget Increase Medicare Payment Advisory Commission (MedPAC) Executive Director James Mathews Shares His Thoughts on Medicare Telehealth and notable research and news developments
Over 35,000 Americans provided comments on the Drug Enforcement Administration's (DEA) proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation." In comment letters responding to the DEA's proposed rule, hundreds of key stakeholders highlighted the need for a special registration for telemedicine and [...]
Journal of Medical Regulation: Increasing Access to a Diverse Mental Health Workforce Through Emergency Reciprocity Licensure New Jersey's COVID-19 Temporary Emergency Reciprocity Licensure Program provided temporary licenses to more than 31,000 out-of-state health care practitioners, over a quarter of whom were mental health providers. As the need for mental health care accelerated during [...]
The Commonwealth Fund: How Primary Care Physicians Experience Telehealth According to a Commonwealth Fund survey of primary care physicians in 10 countries, telehealth platforms have been relatively easy to implement, and most clinicians are satisfied with the technology. In at least half the countries surveyed, including the U.S., most physicians said telehealth improved timeliness [...]
mHealth Intelligence: Preference for Future Telehealth Use Does Not Exceed That of In-Person Care Research published in the Practice of Medicine described that although telehealth gained a high level of approval and application throughout the COVID-19 pandemic, most users prefer to return to in-person care in the future, largely due to a lack [...]
This update includes: Alliance Submits Comments to DEA Proposed Rule on Prescribing Controlled Substance via Telemedicine Mental Health Groups Call on DEA for Continued Access to Treatments Through Telehealth Alliance Co-Leads Letter in Support of the Telehealth Benefit Expansion for Workers Act Statement on the Telehealth Expansion Act of 2023 and notable research [...]
The Alliance for Connected Care and other leading organizations called on the Biden Administration to make modifications to the Drug Enforcement Administration's (DEA) proposed rule, Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation, to ensure more flexible prescribing limitations for providers when a controlled [...]
The Alliance for Connected Care co-led a letter signed by more than 40 organizations in support of the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), which would permanently treat telehealth services as an excepted benefit. During the COVID-19 public health emergency (PHE), the Departments of Labor, Health and Human Services, and [...]
The Alliance for Connected Care submitted comments in response to the request for information from the Drug Enforcement Administration's (DEA) proposed rule, Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation. The Alliance highlights its concerns that the rule does not satisfy multiple congressional [...]
Journal of the American Academy of Dermatology: Efficacy, Perception, and Utilization of Pediatric Teledermatology A study found that telemedicine is effective for the diagnosis and treatment of multiple dermatological conditions in the pediatric community, with significant patient and provider satisfaction. The study found that diagnostic concordance between pediatric teledermatologist and in-person dermatologist varied from 70 [...]